21 CFR 520.246

§ 520.246 Butorphanol tablets.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 520.246, § 520.246 Butorphanol tablets, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87091
Permanent ID: ys:prov:87091@1
SHA-256: 8fca51dcdf1749764c918ec7a3bae3a7c7f68b2b0615ce7de5bf517edb02150b

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each tablet contains butorphanol tartrate equivalent to 1, 5, or 10 milligrams (mg) butorphanol base. (b) Sponsor. See No. 054771 in § 510.600(c) of this chapter. (c) Conditions of use in dogs—(1) Amount. Administer 0.25 mg butorphanol base per pound of body weight. Repeat at intervals of 6 to 12 hours as required. Treatment should not normally be required for longer than 7 days. (2) Indications for use. For the relief of chronic nonproductive cough associated with tracheobronchitis, tracheitis, tonsillitis, laryngitis, and pharyngitis associated with inflammatory conditions of the upper respiratory tract. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.